Your browser doesn't support javascript.
loading
47XXY and 47XXX in Scleroderma and Myositis.
Scofield, R Hal; Lewis, Valerie M; Cavitt, Joshua; Kurien, Biji T; Assassi, Shervin; Martin, Javier; Gorlova, Olga; Gregersen, Peter; Lee, Annette; Rider, Lisa G; O'Hanlon, Terrance; Rothwell, Simon; Lilleker, James; Kochi, Yuta; Terao, Chikacshi; Igoe, Ann; Stevens, Wendy; Sahhar, Joanne; Roddy, Janet; Rischmueller, Maureen; Lester, Sue; Proudman, Susanna; Chen, Sixia; Brown, Matthew A; Mayes, Maureen D; Lamb, Janine A; Miller, Frederick W.
Afiliação
  • Scofield RH; Oklahoma Medical Research Foundation, College of Medicine, University of Oklahoma Health Sciences Center, and Oklahoma City US Department of Veterans Affairs Medical Center, Oklahoma City.
  • Lewis VM; Oklahoma Medical Research Foundation, College of Medicine, University of Oklahoma Health Sciences Center, and Oklahoma City US Department of Veterans Affairs Medical Center, Oklahoma City.
  • Cavitt J; Oklahoma Medical Research Foundation, College of Medicine, University of Oklahoma Health Sciences Center, and Oklahoma City US Department of Veterans Affairs Medical Center, Oklahoma City.
  • Kurien BT; Oklahoma Medical Research Foundation, College of Medicine, University of Oklahoma Health Sciences Center, and Oklahoma City US Department of Veterans Affairs Medical Center, Oklahoma City.
  • Assassi S; University of Texas Health Science Center at Houston McGovern Medical School, Houston, Texas, USA.
  • Martin J; Instituto de Parasitología y Biomedicina López-Neyra, Consejo Superior de Investigaciones Científicas, PTS, Granada, Spain.
  • Gorlova O; Geisel School of Medicine, Dartmouth College and Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA.
  • Gregersen P; Robert S. Boas Center for Genomics and Human Genetics, Feinstein Institutes for Medical Research, Manhasset, New York, USA.
  • Lee A; Robert S. Boas Center for Genomics and Human Genetics, Feinstein Institutes for Medical Research, Manhasset, New York, USA.
  • Rider LG; National Institute of Environmental Health Science, National Institutes of Health, Bethesda, Maryland, USA.
  • O'Hanlon T; National Institute of Environmental Health Science, National Institutes of Health, Bethesda, Maryland, USA.
  • Rothwell S; The University of Manchester, Manchester, UK.
  • Lilleker J; School of Biological Sciences, The University of Manchester, Manchester, UK, and Salford Royal National Health Service Foundation Trust, Salford, UK.
  • Kochi Y; Tokyo, Japan, and RIKEN Center for Integrative Medical Sciences, Tokyo Medical and Dental University, Yokohama, Japan.
  • Terao C; RIKEN Center for Integrative Medical Sciences, Yokohama, Japan, and Shizuoka General Hospital and School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.
  • Igoe A; Oklahoma Medical Research Foundation, Oklahoma City.
  • Stevens W; St. Vincent's Hospital, Melbourne, Victoria, Australia.
  • Sahhar J; Monash Medical Centre, Melbourne, Victoria, Australia.
  • Roddy J; Fiona Stanley Hospital, Murdoch, Western Australia, Australia.
  • Rischmueller M; The Queen Elizabeth Hospital and University of Adelaide, Woodville, South Australia, Australia.
  • Lester S; The Queen Elizabeth Hospital and University of Adelaide, Woodville, South Australia, Australia.
  • Proudman S; Royal Adelaide Hospital, Adelaide, South Australia, Australia.
  • Chen S; College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City.
  • Brown MA; Faculty of Life Sciences and Medicine, King's College London, London, UK.
  • Mayes MD; University of Texas Health Science Center at Houston McGovern Medical School, Houston, Texas, USA.
  • Lamb JA; The University of Manchester, Manchester, UK.
  • Miller FW; National Institute of Environmental Health Science, National Institutes of Health, Bethesda, Maryland, USA.
ACR Open Rheumatol ; 4(6): 528-533, 2022 Jun.
Article em En | MEDLINE | ID: mdl-35352506
OBJECTIVE: We undertook this study to examine the X chromosome complement in participants with systemic sclerosis (SSc) as well as idiopathic inflammatory myopathies. METHODS: The participants met classification criteria for the diseases. All participants underwent single-nucleotide polymorphism typing. We examined X and Y single-nucleotide polymorphism heterogeneity to determine the number of X chromosomes. For statistical comparisons, we used χ2 analyses with calculation of 95% confidence intervals. RESULTS: Three of seventy men with SSc had 47,XXY (P = 0.0001 compared with control men). Among the 435 women with SSc, none had 47,XXX. Among 709 men with polymyositis or dermatomyositis (PM/DM), seven had 47,XXY (P = 0.0016), whereas among the 1783 women with PM/DM, two had 47,XXX. Of 147 men with inclusion body myositis (IBM), six had 47,XXY, and 1 of the 114 women with IBM had 47,XXX. For each of these myositis disease groups, the excess 47,XXY and/or 47,XXX was significantly higher compared with in controls as well as the known birth rate of Klinefelter syndrome or 47,XXX. CONCLUSION: Klinefelter syndrome (47,XXY) is associated with SSc and idiopathic inflammatory myopathies, similar to other autoimmune diseases with type 1 interferon pathogenesis, namely, systemic lupus erythematosus and Sjögren syndrome.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article